Company Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Generics, Innovative Medicines and Over-the-counter Products
100.0
%
| 14,925 | 100.0 % | 15,846 | 100.0 % | +6.17% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
51.3
%
| 7,452 | 49.9 % | 8,124 | 51.3 % | +9.02% |
Europe
30.5
%
| 4,525 | 30.3 % | 4,837 | 30.5 % | +6.90% |
International
12.4
%
| 1,903 | 12.8 % | 1,958 | 12.4 % | +2.89% |
Global
5.8
%
| 1,045 | 7.0 % | 926 | 5.8 % | -11.39% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Eric Drapé
COO | Chief Operating Officer | 62 | 12-12-31 |
Kathleen Veit
CMP | Compliance Officer | - | 09-12-31 |
Amir Elstein
BRD | Director/Board Member | 67 | 94-12-31 |
Yael Ashman
IRO | Public Communications Contact | - | 09-08-31 |
Ran Meir
IRC | Investor Relations Contact | - | - |
Amir Weiss
AUD | Comptroller/Controller/Auditor | 47 | 12-05-31 |
Dov Bergwerk
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
Roberto Mignone
BRD | Director/Board Member | 52 | 17-07-13 |
Amir Elstein
BRD | Director/Board Member | 67 | 94-12-31 |
Rosemary Crane
BRD | Director/Board Member | 64 | 15-08-31 |
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Perry Nisen
BRD | Director/Board Member | 68 | 17-07-13 |
Tal Zaks
BRD | Director/Board Member | 58 | 21-09-30 |
Director/Board Member | 52 | 18-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,238,640,597 | 1,111,231,488 ( 89.71 %) | 106,000,000 ( 8.558 %) | 89.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
MEDIKA D.D. 25.32% | 7,646 | 25.32% | 61,106,834 $ |
Company contact information
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
6944020, Tel Aviv
+972 3 914 8213
http://www.tevapharm.comGroup companies
Name | Category and Sector |
---|---|
Teva Pharmaceutical Finance Co. BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands III BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands II BV
|
Finance/Rental/Leasing
|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. |
Pharmaceuticals: Major
|
Teva Pharmaceutical Finance IV BV
|
Finance/Rental/Leasing
|
Teva Finance Services BV
| |
Teva Finance Services II BV
| |
Actavis Holding Asia BV
Actavis Holding Asia BV Financial ConglomeratesFinance Part of AbbVie, Inc., Actavis Holding Asia BV operates as a holding Dutch company. The private company is based in Haarlem, Netherlands. |
Financial Conglomerates
|
Watson Pharma Pvt Ltd.
Watson Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Watson Pharma Pvt Ltd. is a pharmaceutical company founded in 2005. The private company is based in Mumbai, India. The Indian company manufactures and supplies pharmaceutical products. |
Pharmaceuticals: Major
|
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |